EFFECT OF MAVACAMTEN ON HEALTH STATUS IN CHINESE PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: RESULTS FROM THE EXPLORER-CN STUDY

被引：0

作者：

Tian, Zhuang ^{[1
]}

Li, Liwen ^{[1
]}

Li, Xiaoyan ^{[1
]}

Wang, Jianan ^{[1
]}

Zhang, Qing ^{[1
]}

Li, Zhanquan ^{[1
]}

Peng, Daoquan ^{[1
]}

Yang, Ping ^{[1
]}

Ma, Wei ^{[1
]}

Wang, Fang ^{[1
]}

Jin, Wei ^{[1
]}

Cheng, Xiang ^{[1
]}

Humphries, Michael John ^{[1
]}

Wang, Luojun ^{[1
]}

Fu, Yiqun ^{[1
]}

Zhang, Shuyang ^{[1
]}

机构：

[1] Peking Union Med Coll Hosp, Beijing, Peoples R China

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1284-132

引用

页码：494 / 494

页数：1

共 50 条

[1] Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: The EXPLORER-CN Randomized Clinical Trial
Tian, Zhuang
Li, Liwen
Li, Xiaoyan
Wang, Jian'an
Zhang, Qing
Li, Zhanquan
Peng, Daoquan
Yang, Ping
Ma, Wei
Wang, Fang
Jin, Wei
Cheng, Xiang
Sun, Jing
Fu, Yiqun
Lyu, Cheng
Zhang, Shuyang
JAMA CARDIOLOGY, 2023, 8 (10) : 957 - 965
[2] Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: The EXPLORER-CN Randomized Clinical Trial (vol 8, pg 957, 2023)
Tian, Z.
JAMA CARDIOLOGY, 2024, 9 (07) : 674 - 674
[3] QUANTIFYING HEALTH RELATED QUALITY OF LIFE BENEFITS FROM PATIENTS TREATED WITH MAVACAMTEN FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM) IN CHINA BASED ON THE EXPLORER-CN TRIAL
Cheah, Z.
Simons, C.
Zhong, Y.
Jia, Y.
Hurst, M.
VALUE IN HEALTH, 2024, 27 (12)
[4] EXPLORER-HCM: mavacamten in the treatment of symptomatic hypertrophic obstructive cardiomyopathy
Rapezzi, Claudio
GIORNALE ITALIANO DI CARDIOLOGIA, 2021, 22 (01) : 30 - 32
[5] Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
Hegde, Sheila M.
Lester, Steven J.
Solomon, Scott D.
Michels, Michelle
Elliott, Perry M.
Nagueh, Sherif F.
Choudhury, Lubna
Zemanek, David
Zwas, Donna R.
Jacoby, Daniel
Wang, Andrew
Ho, Carolyn Y.
Li, Wanying
Sehnert, Amy J.
Olivotto, Iacopo
Abraham, Theodore P.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (25) : 2518 - 2532
[6] Study design and rationale of EXPLORER-CN: a phase III, randomised, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of mavacamten in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy
Tian, Zhuang
Wang, Fang
Jin, Wei
Zhang, Qing
Zhou, Jingmin
Yang, Ping
Wang, Geng
Hsu, Peiwen
Sun, Jing
Zhang, Shuyang
Han, Yaling
BMJ OPEN, 2023, 13 (06):
[7] THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS WITH OR WITHOUT HYPERTENSION: ANALYSIS OF THE EXPLORER-HCM TRIAL
Wang, Andrew
Spertus, John A.
Wojdyla, Daniel M.
Abraham, Theodore P.
Nilles, Ester Kim
Owens, Anjali Tiku
Saberi, Sara
Cresci, Sharon
Sehnert, Amy
Lakdawala, Neal K.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 325 - 325
[8] Study Design and Rationale of EXPLORER-HCM Evaluation of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Ho, Carolyn Y.
Olivotto, Iacopo
Jacoby, Daniel
Lester, Steven J.
Roe, Matthew
Wang, Andrew
Waldman, Cynthia Burstein
Zhang, David
Sehnert, Amy J.
Heitner, Stephen B.
CIRCULATION-HEART FAILURE, 2020, 13 (06) : E006853
[9] MANAGEMENT OF HYPERTENSION IN PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY TREATED WITH MAVACAMTEN
Reza, Nosheen
Marzolf, Amy B.
Hornsby, Nicole
de Feria, Alejandro
Owens, Anjali Tiku
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 564 - 564
[10] Mavacamten Favorably Impacts Key Pathophysiologic Processes in Obstructive Hypertrophic Cardiomyopathy: Results From the EXPLORER-HCM Study
Hegde, Sheila M.
Abraham, Theodore P.
Jacoby, Daniel
Wang, Andrew
Ho, Carolyn
Li, Wanying
Sehnert, Amy J.
Solomon, Scott D.
Olivotto, Iacopo
Lester, Steven J.
CIRCULATION, 2020, 142

← 1 2 3 4 5 →